The use of skin Fe levels as a surrogate marker for organ Fe levels, to monitor treatment in cases of iron overload.

A system based on the detection of K-shell x-ray fluorescence (XRF) has been used to investigate whether a correlation exists between the concentration of iron in the skin and the concentration of iron in the liver, as the degree of iron loading increases. The motivation behind this work is to develop a non-invasive method of determining the extent of the body's iron stores via measurements on the skin, in order to monitor the efficacy of chelation therapy administered to patients with beta-thalassaemia. Sprague-Dawley rats were iron loaded via injections of iron dextran and subsequently treated with the iron chelator CP94. The non-haem iron concentrations of the liver, heart and spleen were determined using bathophenanthroline sulphonate as the chromogen reagent. Samples of abdominal skin were taken and the iron concentrations determined using XRF. A strong correlation between the skin iron concentration and the liver iron concentration has been demonstrated (R2 = 0.86). Similar correlations exist for the heart and the spleen. These results show that this method holds great potential as a tool in the diagnosis and treatment of hereditary haemochromatosis and beta-thalassaemia.

[1]  D. Marquardt.  An Algorithm for Least-Squares Estimation of Nonlinear Parameters , 1963 .

[2]  R. Fischer,et al.  Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone , 1995, British journal of haematology.

[3]  B. Leggett,et al.  Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers. , 1997, Journal of hepatology.

[4]  J. Tripp,et al.  Magnetic-susceptibility measurement of human iron stores. , 1982, The New England journal of medicine.

[5]  Bothwell Th,et al.  A simple technique for measuring storage iron concentrations in formalinised liver samples. , 1968 .

[6]  H. Bonkovsky,et al.  Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques. , 1999, Radiology.

[7]  E. Rachmilewitz,et al.  Noninvasive analysis of skin iron and zinc levels in beta-thalassemia major and intermedia. , 1985, The Journal of laboratory and clinical medicine.

[8]  A. Burroughs,et al.  Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. , 1995, Gut.

[9]  A. Giovagnoni,et al.  Limitations of magnetic resonance imaging in measurement of hepatic iron. , 1997, Blood.

[10]  M. Cogswell,et al.  Population-based screening for hemochromatosis using phenotypic and DNA testing among employees of health maintenance organizations in Springfield, Missouri. , 1999, The American journal of medicine.

[11]  D. Bradley,et al.  The feasibility of a sensitive low-dose method for the in vivo evaluation of Fe in skin using K-shell x-ray fluorescence (XRF). , 1999, Physics in medicine and biology.

[12]  M. Skolnick,et al.  Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. , 1988, The New England journal of medicine.

[13]  P. R. Bevington,et al.  Data Reduction and Error Analysis for the Physical Sciences , 1969 .

[14]  G. Brittenham,et al.  Contrasting interspecies efficacy and toxicology of 1, 2 ‐diethy 1–3 ‐hydroxypyridin‐4‐one, CP9 4, relates to differing metabolism of the iron chelating site , 1993, British journal of haematology.

[15]  D. Bradley,et al.  An enhanced sensitivity K-shell x-ray fluorescence technique for tibial lead determination. , 1993, Physics in medicine and biology.

[16]  F. McNeill,et al.  Factors affecting in vivo measurement precision and accuracy of 109Cd K x-ray fluorescence measurements. , 1999, Physics in medicine and biology.

[17]  A. Gouliamos,et al.  Quantification of liver iron overload by T2 quantitative magnetic resonance imaging in thalassemia: impact of chronic hepatitis C on measurements. , 1999, Journal of pediatric hematology/oncology.

[18]  R. Gorodetsky,et al.  Non‐Invasive Evaluation of Iron Load and Clearance in Patients with β‐Thalassemia a , 1990 .

[19]  G. Brittenham,et al.  Iron-chelating therapy and the treatment of thalassemia. , 1997, Blood.

[20]  J. Porter.  Evaluation of new iron chelators for clinical use. , 1996, Acta haematologica.

[21]  R. Fischer,et al.  Assessment of iron stores in children with transfusion siderosis by biomagnetic liver susceptometry , 1999, American journal of hematology.

[22]  L J Somervaille,et al.  In vivo measurement of lead in bone using x-ray fluorescence. , 1985, Physics in medicine and biology.

[23]  D. Mitchell,et al.  Hepatocellular carcinoma: association with increased iron deposition in the cirrhotic liver at MR imaging. , 1999, Radiology.